In 2020, both the estimated U.S. net price and gross price for a one-month supply (28 capsules) of Revlimid Oral Capsule (10mg) were over four times higher than gross prices paid in Australia. In comparison, while less extreme, U.S. prices of Revlimid were still over 2.5 times higher than Canadian.
Revlimid is an immunomodulatory drug used to treat Multiple Myeloma (blood cancer) or anemia in patients with myelodysplastic syndrome.
This statistic shows Revlimid's net and gross prices in the United States compared to gross prices in Australia and Canada as of 2020.
Estimated U.S. prices of Revlimid compared to prices in Australia and Canada as of 2020*
* Prices are for a monthly supply of Revlimid Oral Capsule 10mg (28 capsules).
Estimated U.S. net prices reflect confidential rebates and other price concessions, information on such discounts was not publicly available for the comparison countries. Thus, the actual differences between U.S. prices and those of the other countries were likely larger than GAO estimates in this statistic.
Prices for selected comparison countries—Australia and Canada (Ontario)—were prices listed on their respective public formularies from January 2020 and were converted to U.S. dollars at the relevant monthly Federal Reserve rates.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
GAO. (March 29, 2021). Estimated U.S. prices of Revlimid compared to prices in Australia and Canada as of 2020* [Graph]. In Statista. Retrieved December 04, 2024, from https://www.statista.com/statistics/1237801/us-revlimid-price-comparison-with-other-countries/
GAO. "Estimated U.S. prices of Revlimid compared to prices in Australia and Canada as of 2020*." Chart. March 29, 2021. Statista. Accessed December 04, 2024. https://www.statista.com/statistics/1237801/us-revlimid-price-comparison-with-other-countries/
GAO. (2021). Estimated U.S. prices of Revlimid compared to prices in Australia and Canada as of 2020*. Statista. Statista Inc.. Accessed: December 04, 2024. https://www.statista.com/statistics/1237801/us-revlimid-price-comparison-with-other-countries/
GAO. "Estimated U.S. Prices of Revlimid Compared to Prices in Australia and Canada as of 2020*." Statista, Statista Inc., 29 Mar 2021, https://www.statista.com/statistics/1237801/us-revlimid-price-comparison-with-other-countries/
GAO, Estimated U.S. prices of Revlimid compared to prices in Australia and Canada as of 2020* Statista, https://www.statista.com/statistics/1237801/us-revlimid-price-comparison-with-other-countries/ (last visited December 04, 2024)
Estimated U.S. prices of Revlimid compared to prices in Australia and Canada as of 2020* [Graph], GAO, March 29, 2021. [Online]. Available: https://www.statista.com/statistics/1237801/us-revlimid-price-comparison-with-other-countries/